Johnson & Johnson (NYSE:JNJ) Maintains "Buy" Rating with Optimistic Price Target

Core Viewpoint - Johnson & Johnson (JNJ) is positioned as a strong investment opportunity in the healthcare sector, supported by a raised price target and positive earnings expectations [2][5][6] Group 1: Stock Performance - JNJ's current stock price is $219.90, reflecting a $1.89 increase or 0.87% [3][6] - The stock has a daily trading range between $218.10 and $222.15, with $222.15 being its highest price in the past year [3] - JNJ's market capitalization is approximately $529.8 billion, indicating its significant presence in the healthcare industry [4][6] Group 2: Analyst Ratings and Expectations - Cowen & Co. maintains a "Buy" rating for JNJ and has raised its price target from $222 to $250, indicating optimism about the company's future performance [2][6] - Zacks Investment Research identifies JNJ as a medical stock that could exceed earnings expectations, supported by its Earnings ESP tool [2][6] Group 3: Market Activity - JNJ's trading volume is 2,203,607 shares, indicating active trading and strong investor interest [4][6] - Over the past year, JNJ's lowest price was $141.50, showcasing its growth trajectory [4]